Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Hodge · SciRah

Researcher profile · Semantic Scholar

J. Hodge

Share profile

J. Hodge — researcher profile on SciRah

h-index: 70
Works: 241
Citations: 17K

Most-cited papers

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
L. Galluzzi, I. Vitale, S. Warren, S. Adjemian +50 more
2020Journal for ImmunoTherapy of Cancer993 citations Open access
Semantic Scholar
Consensus guidelines for the detection of immunogenic cell death
O. Kepp, L. Senovilla, I. Vitale, E. Vacchelli +78 more
2014Oncoimmunology806 citations Open access
Semantic Scholar
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D Garg, L. Galluzzi, L. Apetoh, T. Baert +48 more
2015Frontiers in Immunology383 citations Open access
Semantic Scholar
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
M. Bernstein, S. Krishnan, J. Hodge, Joe Y. Chang
2016Nature Reviews Clinical Oncology372 citations Open access
Semantic Scholar
Abstract 632: Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
S. Gameiro, Momodou L. Jammeh, Max M. Wattenberg, K. Tsang +2 more
2014279 citations Open access
Semantic Scholar
Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study
Erika J. Lampert, A. Zimmer, M. Padget, A. Cimino-Mathews +14 more
2020Clinical Cancer Research180 citations Open access
Semantic Scholar
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
C. Jochems, J. Hodge, M. Fantini, Rika Fujii +11 more
2016OncoTarget177 citations Open access
Semantic Scholar
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
Anna R. Kwilas, Andressa Ardiani, R. Donahue, D. Aftab +1 more
2014Journal of Translational Medicine177 citations Open access
Semantic Scholar
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
P. Kim, Anna R. Kwilas, Wen-Xin Xu, Sarah Alter +4 more
2016OncoTarget157 citations Open access
Semantic Scholar
Cisplatin and Oxaliplatin Induce Similar Immunogenic Changes in Preclinical Models of Head and Neck Cancer
So-Jin Park, Wenda Ye, Roy Xiao, Christopher Silvin +4 more
2019Oral Oncology156 citations Open access
Semantic Scholar
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
Kellsye P. Fabian, M. Padget, R. Donahue, K. Solocinski +7 more
2020Journal for ImmunoTherapy of Cancer142 citations Open access
Semantic Scholar
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing
S. Gameiro, Anthony S. Malamas, M. Bernstein, K. Tsang +8 more
2016International Journal of Radiation Oncology, Biology, Physics139 citations Open access
Semantic Scholar
In Vivo Effects of Lattice Radiation Therapy on Local and Distant Lung Cancer: Potential Role of Immunomodulation
S. Kanagavelu, Seema Gupta, Xiao-Dong Wu, S. Philip +5 more
2014Radiation Research127 citations Open access
Semantic Scholar
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation
M. Morisada, Paul E. Clavijo, E. Moore, Lillian D. Sun +6 more
2018Oncoimmunology124 citations Open access
Semantic Scholar
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
C. Jochems, M. Fantini, R. I. Fernando, Anna R. Kwilas +12 more
2016OncoTarget120 citations Open access
Semantic Scholar
Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy
Anna R. Kwilas, R. Donahue, K. Tsang, J. Hodge
2015Cancer Cell & Microenvironment110 citations Open access
Semantic Scholar
From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment
Kellsye P. Fabian, Benjamin Wolfson, J. Hodge
2021Frontiers in Oncology106 citations Open access
Semantic Scholar
Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab
Rika Fujii, E. Friedman, J. Richards, K. Tsang +3 more
2016OncoTarget101 citations Open access
Semantic Scholar
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
S. Gameiro, Anthony S. Malamas, K. Tsang, S. Ferrone +1 more
2016OncoTarget98 citations Open access
Semantic Scholar
Enhanced tumor control with combination mTOR and PD-L1 inhibition in syngeneic oral cavity cancers
E. Moore, Harrison A. Cash, Andria M. Caruso, R. Uppaluri +3 more
2016Cancer immunology research92 citations Open access
Semantic Scholar
Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions
M. Bernstein, Charlie T. Garnett, Huogang Zhang, A. Velcich +5 more
2014Cancer Biotherapy and Radiopharmaceuticals86 citations Open access
Semantic Scholar
Neoadjuvant PD-1 immune checkpoint blockade reverses functional immunodominance among tumor-antigen specific T cells
J. Friedman, E. Moore, P. Zolkind, Y. Robbins +11 more
2019Clinical Cancer Research79 citations Open access
Semantic Scholar
Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
B. Farsaci, R. Donahue, Michael A Coplin, I. Grenga +3 more
2014Cancer immunology research78 citations Open access
Semantic Scholar
Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas’ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation
Anthony S. Malamas, S. Gameiro, K. M. Knudson, J. Hodge
2016OncoTarget77 citations Open access
Semantic Scholar
Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody
T. Nagaya, Yuko Nakamura, Kazuhide Sato, Toshiko Harada +4 more
2016OncoTarget76 citations Open access
Semantic Scholar
Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
Andressa Ardiani, S. Gameiro, Anna R. Kwilas, R. Donahue +1 more
2014OncoTarget72 citations Open access
Semantic Scholar
An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell cytotoxic function from TGF-β1-mediated immunosuppression
Rika Fujii, C. Jochems, S. Tritsch, H. Wong +2 more
2018Cancer Immunology and Immunotherapy70 citations Open access
Semantic Scholar
Rationale for IL-15 superagonists in cancer immunotherapy
K. M. Knudson, J. Hodge, J. Schlom, S. Gameiro
2020Expert Opinion on Biological Therapy67 citations Open access
Semantic Scholar
Overcoming hypoxia-induced functional suppression of NK cells
K. Solocinski, M. Padget, Kellsye P. Fabian, Benjamin Wolfson +7 more
2020Journal for ImmunoTherapy of Cancer67 citations Open access
Semantic Scholar
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
Kellsye P. Fabian, J. Hodge
2021Molecular Therapy: Oncolytics65 citations Open access
Semantic Scholar
Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
K. Hicks, M. Fantini, R. Donahue, Angie Schwab +9 more
2018Oncoimmunology64 citations Open access
Semantic Scholar
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
Kathleen E. Fenerty, M. Padget, Benjamin Wolfson, S. Gameiro +5 more
2018Journal of Immunotherapy for Cancer64 citations Open access
Semantic Scholar
Unlocking the Combination: Potentiation of Radiation-Induced Antitumor Responses with Immunotherapy
Max M. Wattenberg, Ahmed Fahim, Mansoor M. Ahmed, J. Hodge
2014Radiation Research63 citations Open access
Semantic Scholar
Efficient ADCC- killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
Amber J. Giles, Shu-Yu Hao, M. Padget, Hua Song +17 more
2019JCI Insight55 citations Open access
Semantic Scholar
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve
Kellsye P. Fabian, M. Padget, Rika Fujii, J. Schlom +1 more
2021Journal for ImmunoTherapy of Cancer51 citations Open access
Semantic Scholar
Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens
S. Gameiro, Andressa Ardiani, Anna R. Kwilas, J. Hodge
2014Oncoimmunology49 citations Open access
Semantic Scholar
Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials From a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting
J. Bauman, Ezra E. W. Cohen, R. Ferris, D. Adelstein +16 more
2016Cancer48 citations Open access
Semantic Scholar
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
Y. Robbins, Sarah Greene, J. Friedman, Paul E. Clavijo +10 more
2020bioRxiv47 citations Open access
Semantic Scholar
ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody
C. Jochems, J. Hodge, M. Fantini, K. Tsang +3 more
2017International Journal of Cancer47 citations Open access
Semantic Scholar
Humoral response to a viral glycan correlates with survival on PROSTVAC-VF
Christopher T. Campbell, J. Gulley, O. Oyelaran, J. Hodge +2 more
2014Proceedings of the National Academy of Sciences of the United States of America47 citations Open access
Semantic Scholar
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies
J. Friedman, M. Morisada, Lillian D. Sun, E. Moore +5 more
2018Journal of Immunotherapy for Cancer45 citations Open access
Semantic Scholar
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
Maxwell Y. Lee, Y. Robbins, C. Sievers, J. Friedman +11 more
2021Journal for ImmunoTherapy of Cancer38 citations Open access
Semantic Scholar
Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy
K. Hicks, K. M. Knudson, Karin L. Lee, D. Hamilton +8 more
2019Clinical Cancer Research37 citations Open access
Semantic Scholar
Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies
D. Zahavi, J. Hodge
2023International Journal of Molecular Sciences36 citations Open access
Semantic Scholar
The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
E. Gabitzsch, Kwong Y. Tsang, C. Palena, J. David +11 more
2015OncoTarget35 citations Open access
Semantic Scholar
Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation
Kellsye P. Fabian, Josh Kowalczyk, Sandy T Reynolds, J. Hodge
2022Cells34 citations Open access
Semantic Scholar
Vaccine-Mediated Immunotherapy Directed Against a Transcription Factor Driving the Metastatic Process
Andressa Ardiani, S. Gameiro, C. Palena, D. Hamilton +4 more
2014Cancer Research34 citations Open access
Semantic Scholar
Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities
C. Garnett-Benson, J. Hodge, S. Gameiro
2015Seminars in Radiation Oncology33 citations Open access
Semantic Scholar
A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity (ADCC) employing NK or high affinity NK (haNK) cells in combination with cetuximab
Rika Fujii, J. Schlom, J. Hodge
2017Journal of Neurosurgery32 citations Open access
Semantic Scholar
INTRODUCTION
Mansoor M. Ahmed, C. Guha, J. Hodge, E. Jaffee
2014Radiation Research29 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Schlom×21
Invite
J. Schlom — researcher profile on SciRah
S. Gameiro×15
Invite
S. Gameiro — researcher profile on SciRah
M. Padget×11
Invite
M. Padget — researcher profile on SciRah
K. Tsang×8
Invite
K. Tsang — researcher profile on SciRah

×8

Invite

P. Soon-Shiong — researcher profile on SciRah

Anna R. Kwilas×8

Invite

Anna R. Kwilas — researcher profile on SciRah

Invite

C. Allen — researcher profile on SciRah

Invite

R. Donahue — researcher profile on SciRah

Kellsye P. Fabian×7

Invite

Kellsye P. Fabian — researcher profile on SciRah

Invite

Rika Fujii — researcher profile on SciRah

Invite

C. Jochems — researcher profile on SciRah

Invite

M. Fantini — researcher profile on SciRah